Top 10 Challenges And Solutions For Decentralized Clinical Trials

The future of clinical research is increasingly decentralized, driven by the transformative power of digital health and artificial intelligence. While the projected $13.3 billion market size by 2030 underscores the immense potential of DCTs, realizing this potential requires tackling key implementation challenges. Fortunately, innovative solutions leveraging technology, evolving regulatory frameworks, and a focus on the patient experience are emerging. How can the industry overcome obstacles related to data quality, regulatory compliance, and participant engagement in remote trials? In this article you will learn about the top 10 challenges facing DCTs and the innovative strategies designed to solve them.